# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Cantor Fitzgerald analyst Ross Osborn maintains Prenetics Global (NASDAQ:PRE) with a Overweight and lowers the price target ...
Prenetics Global (NASDAQ:PRE) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(0.7...
Initial research project is with NDORMS, Botnar Research Institute, University of Oxford, focusing on accelerated aging in spac...